• News
  • SAN DIEGO
  • BioTech

BioAtla successfully engineers infection antibody

San Diego-based BioAtla and Telephus Medical LLC announced that BioAtla has successfully completed a key protein engineering phase of Telephus' compound TPH 101.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!